Patent Assignment
Reel/Frame 024767/0466
Release of Security Interest
Recorded: 2010-07-30
Received: 2010-07-30
Pages: 40
Assignor
CEQUENT PHARMACEUTICALS, INC.
Executed: 2010-07-28
Assignee
MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
3830 MONTE VILLA PARKWAY, BOTHELL, WA, 98021, UNITED STATES
Covered Properties
(100)
Intranasal Carbetocin Formulations and Methods for the Treatment of Autism
Application:
12/599,267 →
Nucleic Acid Compounds for Inhibiting Survivin Gene Expression and Uses Thereof
Application:
61/318,141 →
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application:
12/726,308 →
Intranasal Administration of Rapid Acting Insulin
Application:
12/672,478 →
Phage Displayed Cell Binding Peptides
Application:
12/701,397 →
Amino Acid-Based Nanoparticle Formulations
Application:
61/258,115 →
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
Application:
12/580,250 →
Rna Complexes Comprising Acyclic Nucleomonomers
Application:
61/252,085 →
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application:
12/552,082 →
Ribonucleic Acids with Non-Standard Bases and Uses Thereof
Application:
12/486,889 →
Dual Synchro-Resonant Electrosurgical Apparatus with Bi-Directional Magnetic Coupling
Application:
12/477,320 →
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Application:
12/515,403 →
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Application:
12/445,868 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Application:
12/445,575 →
Compositions and Methods for Efficient Delivery of Gene Silencing Therapeutics
Application:
61/167,379 →
Compositions for Intranasal Delivery of Human Insulin and Uses Thereof
Application:
12/376,205 →
Rna Oligonucleotides and Rna Complexes Comprising Acyclic Nucleomonomers
Application:
61/119,624 →
Compositions and Methods for Triggered Release Therapeutics
Application:
61/116,258 →
Compositions and Methods for Liposomal Rna Therapeutics
Application:
61/106,062 →
Compositions for Enhanced Epithelial Permeation of Neuropeptide Y for Treating Obesity
Application:
12/234,547 →
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Application:
12/206,165 →
Modification of Double-Stranded Ribonucleic Acid Molecules
Application:
12/065,604 →
Uses of Broad Spectrum Rnai Therapeutics Against Influenza
Application:
12/189,563 →
Phosphorous Pentoxide Producing Methods
Application:
12/186,413 →
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereo
Application:
61/086,445 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application:
61/086,435 →
Ribonucleic Acids with Non-Standard Bases and Uses Thereof
Application:
61/073,633 →
Lipophilic Amines and Uses Thereof
Application:
61/057,153 →
Phosphorous Pentoxide Producing Methods
Application:
12/125,751 →
Amino Acid Lipids and Uses Thereof
Application:
12/114,284 →
Tight Junction Modulating Peptide Components for Enhancing Mucosal Delivery of Therapeutic Agents
Application:
11/997,132 →
Dispersion Compositions for Interfering Rna and Uses Thereof
Application:
61/022,571 →
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Application:
12/013,274 →
Phage Displayed Trp Cage Ligands
Application:
11/955,207 →
Uses of Broad Spectrum Rnai Therapeutics Against Influenza
Application:
60/979,772 →
Rnai Therapeutic for Respiratory Virus Infection
Application:
11/910,971 →
Lipopeptides for Delivery of Interfering Rna Agents
Application:
60/976,894 →
Genetic inhibition by double-stranded RNA
Application:
11/905,449 →
Genetic Inhibition of Double-Stranded Rna
Application:
11/905,368 →
Emulsion Compositions for Interfering Rna and Uses Thereof
Application:
60/972,590 →
Amino Acid Lipids and Uses for Rna Therapeutics
Application:
60/972,653 →
Compositions and Methods of Using Double-Stranded Nucleic Acid Molecules Containing One or More Gap or Nick
Application:
60/969,136 →
Compositions and Methods of Using Double-Stranded Nucleic Acid Molecules Containing One or More Gap or Nick
Application:
60/955,317 →
Rna Therapeutics for Drug Resistant Influenza
Application:
60/955,314 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application:
60/953,667 →
Genetic inhibition by double-stranded RNA
Application:
11/826,385 →
Device for Improved Peptide Delivery
Application:
11/774,492 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application:
60/947,282 →
Phosphorous Pentoxide Producing Methods
Application:
11/818,115 →
Intranasal Carbetocin Formulations and Methods for Treatment of Autism
Application:
60/942,607 →
FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
Application:
11/750,979 →
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application:
11/744,745 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application:
60/916,131 →
COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY
Application:
11/743,480 →
Compositions and Methods of Using Gapped or Nicked Double Stranded Nucleic Acid Molecules
Application:
60/910,393 →
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Application:
11/576,139 →
Rnai Therapeutic for Respiratory Virus Infection
Application:
11/687,564 →
Intranasal Administration of Rapid Acting Insulin
Application:
60/894,130 →
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
Application:
11/676,221 →
Compositions and Methods for Complexes of Nucleic Acids and Organic Cations
Application:
11/676,226 →
Phage Displayed Cell Binding Peptides
Application:
11/627,863 →
Method for Opening Tight Junctions
Application:
11/624,630 →
Dry Powder Compositions for Rna Influenza Therapeutics
Application:
11/623,306 →
COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX
Application:
11/610,403 →
Intranasal Administration of Rapid Acting Insulin
Application:
60/868,703 →
Compositions for Enhanced Epithelial Permeation of Peptide Yy for Treating Obesity
Application:
11/561,331 →
Method of Manufacturing Walk-in Tubs
Application:
11/551,160 →
COMPOSITIONS AND METHODS EMPLOYING GAPPED OR NICKED siRNA MOLECULES
Application:
60/862,027 →
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application:
11/550,051 →
Compositions and Methods for the Treatment of Psychiatric Disorders
Application:
11/537,468 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Application:
60/825,878 →
Intranasal Administration of Rapid Acting Insulin
Application:
60/825,876 →
Phage Displayed Cell Binding Peptides
Application:
60/823,894 →
Peptide-Dicer Substrate Rna Conjugates as Delivery Vehicles for Sirna
Application:
60/822,896 →
Intranasal administration of rapid acting insulin
Application:
60/821,525 →
Device for improved peptide delivery
Application:
60/821,528 →
Intranasal Administration of a Rapid Acting Insulin Formulation
Application:
60/806,904 →
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
Application:
60/803,175 →
Compositions and Methods for Complexes of Nucleic Acids and Organic Cations
Application:
60/803,065 →
FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
Application:
60/747,622 →
Hair Dye Brush Handle
Application:
29/259,752 →
Compositions and methods for lipid and polypeptide based siRNA intracellular delivery
Application:
60/798,243 →
Compositions and methods employing universal-binding nucleotides for targeting multiple gene variants with a single siRNA duplex
Application:
60/796,274 →
Stable pharmaceutical dosage forms of teriparatide
Application:
11/390,940 →
Intranasal administration of rapid acting insulin
Application:
60/778,724 →
Phage displayed cell binding peptides
Application:
60/774,496 →
Stabilized teriparatide solution
Application:
11/347,554 →
Method of delivering parathyroid hormone to a human
Application:
11/347,551 →
Dry powder compositions
Application:
60/760,714 →
Peptide mediated cellular uptake of double stranded RNA
Application:
60/733,664 →
Peptide-dicer substrate RNA conjugates as delivery vehicles for siRNA
Application:
60/733,665 →
Intranasal administration of insulin
Application:
60/728,877 →
Peptide-mediated sirna uptake into cells
Application:
60/727,216 →
Method of treating osteoporosis using intranasal parathyroid hormone
Application:
11/246,406 →
GRAS composition for enhanced mucosal delivery of parathyroid hormone
Application:
11/246,450 →
Chemically modified double-stranded ribonucleic acid molecules
Application:
60/720,072 →
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
Application:
11/223,699 →
Double-stranded ribonucleic acid molecules having ribothymidine
Application:
11/219,625 →
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application:
11/126,996 →
Anti-viral compositions and methods of use thereof
Application:
60/669,942 →